The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth.
The global hospital acquired infection control market was valued at $29.1 billion in 2021 and is expected to reach $31.3 billion by 2026, growing at a compound annual growth rate of 1.5%, according to a new report by MarketsandMarkets.\Request for Free Sample ReportThe modest growth expected in the market can be attributed to factors like the high incidence
The global healthcare supply chain management market is expected to reach $3.3 billion by 2025, representing a healthy compound annual growth rate of 7.9% between 2020 and 2025.
The healthcare fraud analytics market is poised for robust growth over the next several years, according to a new report from MarketsandMarkets. The market was valued at $1.5 billion in 2021 and is expected to reach $5 billion by 2026, reflecting a compound annual growth rate of 26.7%.Several key factors are driving growth in the healthcare fraud analytics sector.
According to a new report by MarketsandMarkets, the global bioprocess containers market size is projected to reach USD 9.6 billion by 2026, growing at a compound annual growth rate (CAGR) of 26.3% during the forecast period. Bioprocess containers like bags and accessories are single-use disposable containers used in biopharmaceutical manufacturing.
The global dental 3D printing market is poised for robust growth over the next several years, according to a new report from MarketsandMarkets.
The global Real World Evidence Solutions Market is poised for robust growth in the coming years, according to a new report from marketsandmarkets. The market, valued at $1.5 billion in 2022, is projected to reach $2.9 billion by 2027, reflecting a compound annual growth rate (CAGR) of 15.2%.RWE refers to data regarding the usage, benefits and risks of medical products derived from real-world settings.
The global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) market shows strong growth potential in the coming years, according to a new report from MarketsandMarkets.
The global EliSpot and FluoroSpot assay market is poised for strong growth in the coming years, according to a new report from MarketsandMarkets.
The global live cell imaging market is projected to grow at a CAGR of 10.2% from 2023 to 2028, reaching $4.3 billion by the end of the forecast period according to a new report by MarketsandMarkets. Key factors driving this growth include the increasing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of research funding.
